CORD-19:c654596857bce9cdd64ffc51842048643107348c / 139241-139461
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1159","span":{"begin":0,"end":220},"obj":"Sentence"},{"id":"T2160","span":{"begin":0,"end":220},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The efficacy and safety of moxifloxacin (MXF) 400 mg once daily for 7 days was evaluated in the treatment of acute maxillary sinusitis after first-line therapy failure, or acute sinusitis with high risk of complications."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T342","span":{"begin":0,"end":220},"obj":"Sentence"}],"text":"The efficacy and safety of moxifloxacin (MXF) 400 mg once daily for 7 days was evaluated in the treatment of acute maxillary sinusitis after first-line therapy failure, or acute sinusitis with high risk of complications."}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T192","span":{"begin":125,"end":134},"obj":"Phenotype"},{"id":"T193","span":{"begin":172,"end":187},"obj":"Phenotype"}],"attributes":[{"id":"A192","pred":"hp_id","subj":"T192","obj":"http://purl.obolibrary.org/obo/HP_0000246"},{"id":"A193","pred":"hp_id","subj":"T193","obj":"http://purl.obolibrary.org/obo/HP_0000255"}],"text":"The efficacy and safety of moxifloxacin (MXF) 400 mg once daily for 7 days was evaluated in the treatment of acute maxillary sinusitis after first-line therapy failure, or acute sinusitis with high risk of complications."}
CORD-19-PD-UBERON
{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T116","span":{"begin":115,"end":134},"obj":"Body_part"}],"attributes":[{"id":"A116","pred":"uberon_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/UBERON_0001764"}],"text":"The efficacy and safety of moxifloxacin (MXF) 400 mg once daily for 7 days was evaluated in the treatment of acute maxillary sinusitis after first-line therapy failure, or acute sinusitis with high risk of complications."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T562","span":{"begin":109,"end":134},"obj":"Disease"},{"id":"T563","span":{"begin":115,"end":134},"obj":"Disease"},{"id":"T564","span":{"begin":125,"end":134},"obj":"Disease"},{"id":"T565","span":{"begin":178,"end":187},"obj":"Disease"},{"id":"T97764","span":{"begin":109,"end":134},"obj":"Disease"},{"id":"T14230","span":{"begin":115,"end":134},"obj":"Disease"},{"id":"T35131","span":{"begin":125,"end":134},"obj":"Disease"},{"id":"T522","span":{"begin":178,"end":187},"obj":"Disease"}],"attributes":[{"id":"A562","pred":"mondo_id","subj":"T562","obj":"http://purl.obolibrary.org/obo/MONDO_0002186"},{"id":"A563","pred":"mondo_id","subj":"T563","obj":"http://purl.obolibrary.org/obo/MONDO_0005842"},{"id":"A564","pred":"mondo_id","subj":"T564","obj":"http://purl.obolibrary.org/obo/MONDO_0005961"},{"id":"A565","pred":"mondo_id","subj":"T565","obj":"http://purl.obolibrary.org/obo/MONDO_0005961"},{"id":"A55021","pred":"mondo_id","subj":"T97764","obj":"http://purl.obolibrary.org/obo/MONDO_0002186"},{"id":"A67752","pred":"mondo_id","subj":"T14230","obj":"http://purl.obolibrary.org/obo/MONDO_0005842"},{"id":"A16944","pred":"mondo_id","subj":"T35131","obj":"http://purl.obolibrary.org/obo/MONDO_0005961"},{"id":"A77432","pred":"mondo_id","subj":"T522","obj":"http://purl.obolibrary.org/obo/MONDO_0005961"}],"text":"The efficacy and safety of moxifloxacin (MXF) 400 mg once daily for 7 days was evaluated in the treatment of acute maxillary sinusitis after first-line therapy failure, or acute sinusitis with high risk of complications."}